Drug Sickle Cell

Endari

Payments companies reported to CMS as associated with Endari. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$326Kassociated payments (2023-2025)
626clinicians with associated payments
1company reporting

By year

2023 $123K
2024 $198K
2025 $5,121

Payments reported as associated with Endari, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Pediatrics $279K
Hematology & Oncology $9,176
Pediatric Hematology-Oncology $8,389
Family $7,028
Internal Medicine $5,817
Nurse Practitioner $3,325

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Endari

These are the largest totals companies reported as associated with Endari. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Corey Hebert Gretna, LA Pediatrics $278,356.98
Brian Berman Detroit, MI Pediatric Hematology-Oncology $6,401.99
Nirmish Shah Durham, NC Internal Medicine $4,534.91
Ugochi Ogu Memphis, TN Hematology & Oncology $2,935.00
Artangela Henry Memphis, TN Adult Health (Nurse Practitioner) $2,152.63
Anthony Onyegbula Stockbridge, GA Hematology & Oncology $970.14
Shamiel Riley Columbia, SC Family $845.66
Jennifer Saunders Charlotte, NC Nurse Practitioner $764.12
Michelle Fields Columbia, SC Family $698.84
Fregi Vazhappully Francis Memphis, TN Family $466.07

Prescribed Endari?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.